Furthermore, miR-181a has been shown to selectively induce B-lymphocyte proliferation, particularly in pediatric ALL (P-ALL) by downregulating genes such as EGR1, which functions as inhibitors of the cell cycle [115,116]. This evidence concerns the gene EGR1 and acute lymphoblastic leukemia.